PTPA and hepatocellular carcinoma: Our previous study demonstrated that the CIP2A-PP2A-AKT pathway mediated the sensitizing effect of bortezomib on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell apoptosis in HCC [21].